Edora/Evity/Enitra pacemaker series gives patients access to ultra-high field MRIs without scanning area restrictions
BIOTRONIK has received CE approval for 3 tesla (T) full-body scans (FBS) with its latest range of MR conditional pacemaker systems.
Patients implanted with single- and dual-chamber pacemakers from the Edora/Evity/Enitra series can now benefit from ultra-high field MRI scans without any restrictions on the scanned body area.
BIOTRONIK’s ProMRI pacemaker portfolio was previously approved for 1.5 T FBS.
With more options for cardiac imaging, we can strive to improve care for patients with pacemakers
With 3 T FBS compatibility, radiologists can offer pacemaker patients additional high-quality imaging options.
Approval for full-body scanning with 3 T makes it is possible to scan areas of the body that are typically off limits for pacemaker patients, including the breast, heart, abdomen and spine.
“As 3 T MRI becomes increasingly prevalent in the management of a variety of diseases, it is vital that pacemaker patients also have access to this invaluable mode of imaging,” said Dr Matthias Schmitt of the University Hospital of South Manchester NHS Foundation Trust.
“Thoracic imaging at higher field strengths has improved significantly in recent years, allowing 3 T MRI to take on a significant role in cardiac imaging for events such as cardiac perfusion, cardiac toxicity and myocardial infarction, where visualisation is key in guiding clinical decision-making.
“With more options for cardiac imaging, we can strive to improve care for patients with pacemakers.”
In addition to benefitting from cardiac imaging; pacemaker patients are able to undergo ultra-high field MRIs for a variety of comorbidities, such as cancers or neurological disorders that require indepth tissue examination.
We endeavour to break down barriers that prevent device patients from safely undergoing the MRI scanning they need
Three-tesla MRI is often the preferred modality for brain imaging, for example, in cases of multiple sclerosis, brain tumours, and complex vascular brain imaging.
“We endeavour to break down barriers that prevent device patients from safely undergoing the MRI scanning they need,” said Manuel Ortega, senior vice president at BIOTRONIK.
“With 3 T FBS approval for our latest range of pacemakers, we’re excited to enable patients to undergo ultra-high field MRIs without any area restrictions.”
To complement the ProMRI cardiac device range, BIOTRONIK’s online tool ProMRIcheck.com enables physicians to prospectively or retrospectively check the MR conditions of any BIOTRONIK device system according to device model, lead types and individual country regulations.